CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 136 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $80,000 | -17.5% | 11,382 | -2.3% | 0.24% | +5.4% |
| Q1 2022 | $97,000 | -17.8% | 11,645 | -33.4% | 0.22% | +18.0% |
| Q4 2021 | $118,000 | -7.1% | 17,493 | -26.9% | 0.19% | +22.7% |
| Q3 2021 | $127,000 | -53.1% | 23,942 | -49.2% | 0.15% | -51.6% |
| Q2 2021 | $271,000 | +12.4% | 47,094 | -9.7% | 0.32% | +20.0% |
| Q1 2021 | $241,000 | +17.0% | 52,181 | +16.8% | 0.26% | -10.8% |
| Q2 2020 | $206,000 | +17.0% | 44,664 | -2.2% | 0.30% | +4.2% |
| Q1 2020 | $176,000 | +1.7% | 45,674 | -0.8% | 0.28% | +85.1% |
| Q4 2019 | $173,000 | – | 46,042 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |